Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers-Reference-Cited by-同舟云学术

Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers

Published:2006-07 Issue:7 Volume:46 Page:792-801
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Li Susie Xiujiang,Pequignot Edward,Panebianco Deborah,Lupinacci Paul,Majumdar Anup,Rosen Laura,Ahmed Tuli,Royalty Jane E.,Rushmore Thomas H.,Murphy M. Gail,Petty Kevin J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: results from a randomized, double-blind, placebo-controlled trial in Latin America;Poli-Bigelli;Cancer,2003

2. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy;Warr;J Clin Oncol.,2005

3. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin: the Aprepitant Protocol 052 Study Group;Hesketh;J Clin Oncol.,2003

4. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone;Campos;J Clin Oncol.,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy Subjects;The Journal of Clinical Pharmacology;2018-04-25

2. Aprepitant and fosaprepitant drug interactions: a systematic review;British Journal of Clinical Pharmacology;2017-06-10

3. Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy;Expert Opinion on Drug Safety;2017-05-25

4. Drugs as victims and perpetrators and the pharmacokinetic concept of maximum exposure;Handbook of Metabolic Pathways of Xenobiotics;2014-01-15

5. Aprepitant: drug–drug interactions in perspective;Annals of Oncology;2010-12